NCT00004931View on ClinicalTrials.gov

Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

2,472

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

September 30, 2005

Conditions

Stage II Colon CancerStage III Colon Cancer

Interventions

DRUG

leucovorin calcium

Given IV

DRUG

fluorouracil

Given IV

DRUG

oxaliplatin

Given IV

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

15212-5234

National Surgical Adjuvant Breast and Bowel Project, Pittsburgh

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT00004931 - Fluorouracil Plus Leucovorin With or Without Oxaliplatin in Treating Patients With Stage II or Stage III Colon Cancer | Biotech Hunter | Biotech Hunter